Mark Avagliano - 01 Jul 2024 Form 4 Insider Report for G1 Therapeutics, Inc.

Role
Chief Business Officer
Signature
/s / Monica Roberts Thomas, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Jul 2024
Net transactions value
$0
Form type
4
Filing time
03 Jul 2024, 17:26:01 UTC
Previous filing
15 May 2024
Next filing
08 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +35,000 +17% $0.000000 244,683 01 Jul 2024 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests 50% on July 1, 2025 and 50% on July 1, 2026, subject to the Reporting Person's continued service through each applicable vesting date.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 Represents (i) 23,223 shares of common stock; (ii) 2,750 RSUs from award granted on January 4, 2021; (iii) 6,000 RSUs from award granted on January 3, 2022; (iv) 15,450 RSUs from award granted on January 3, 2023; (v) 17,500 RSUs from award granted on May 10, 2023; (vi) 44,760 RSUs from award granted on January 3, 2024; (vii) 100,000 RSUs from award granted on March 20, 2024; and (viii) 35,000 RSUs from award granted on July 1, 2024.